NBO Pharma
nbopharma.com
Actively hiring
Health Care
Rare Disease Therapeutics
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$7.6M
1 round on record
Latest round
$7.6M
Venture round · Jun 2025 · 16 mo ago
Team
51-200
employees, estimated range
The money's age
Due for its next round
16 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jun 2025 | $7.6M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | NBO Pharma Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Fredric PriceExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
US FDA Grants Orphan Drug and Rare Pediatric Disease Designations to GEn1E Lifesciences' Dual Signal Modulator for the Treatment of…
Mahzi aims to unite patient and family groups, academic researchers, other industry members, and our internal team of experts to develop…
Oak Hill Bio is a clinical-stage biotechnology company focused on acquiring and developing outstanding rare disease drugs that have been…
Company Overview Rooted in two decades of discovery Santero Therapeutics is a Belgian biotechnology company developing first-in-class…
Willkommen bei Amgen, einem führenden globalen Biotechnologie-Unternehmen. Mit allem, was wir tun, verfolgen wir ein klares Ziel…
Human cells cannot degrade cholesterol, leading to several chronic and orphan diseases. Repair Biotechnologies’ Cholesterol Degrading…
Overview
NBO (acronym for Nasal Bioavailability of Octreotide) Pharma Inc. was incorporated in 2021 to develop a drug for the treatment of Idiopathic Intracranial Hypertension [IIH] for which no drugs are approved.
People
Fredric Price
Executive Officer, Director
Robert Friedman
Director
Colin Foster
Director
Bard Geesaman
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
New York
United States
HQ
Contact
50-200 est. staff
Bedford, New York 10506 USA
Financials
Total raised
$7.6M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2025 | $7.6M | Details |